Promoting exercise after a cancer diagnosis: easier said than done

le Hudis, C A, Jones, L
Foilsithe 2014

Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)

le Ruddy, K. J., Pitcher, B. N., Archer, L. E., Cohen, H. J., Winer, E. P., Hudis, C. A., Muss, H. B., Partridge, A. H.
Foilsithe 2012

Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer

le Baselga, J., Manikhas, A., Cortés, J., Llombart, A., Roman, L., Semiglazov, V. F., Byakhov, M., Lokanatha, D., Forenza, S., Goldfarb, R. H., Matera, J., Azarnia, N., Hudis, C. A., Rozencweig, M.
Foilsithe in Ann Oncol (2014)

Corrections to “Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer”

le Baselga, J., Manikhas, A., Cortés, J., Llombart, A., Roman, L., Semiglazov, V.F., Byakhov, M., Lokanatha, D., Forenza, S., Goldfarb, R.H., Matera, J., Azarnia, N., Hudis, C.A., Rozencweig, M.
Foilsithe in Ann Oncol (2019)

A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer

le Fornier, M. N., Morris, P. G., Abbruzzi, A., D'Andrea, G., Gilewski, T., Bromberg, J., Dang, C., Dickler, M., Modi, S., Seidman, A. D., Sklarin, N., Chang, J., Norton, L., Hudis, C. A.
Foilsithe in Ann Oncol (2011)

Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer

le Morris, P.G., Rota, S, Cadoo, K, Zamora, S, Patil, S, D’Andrea, G., Gilewski, T., Bromberg, J., Dang, C., Dickler, M., Modi, S., Seidman, A.D., Sklarin, N., Norton, L, Hudis, C.A., Fornier, M.N.
Foilsithe in Clin Breast Cancer (2018)

Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from...

le Smyth, L. M., Iyengar, N. M., Chen, M. F., Popper, S. M., Patil, S, Wasserheit-Lieblich, C., Argolo, D. F., Singh, J. C., Chandarlapaty, S, Sugarman, S. M., Comen, E. A., Drullinsky, P. R., Traina, T. A., Troso-Sandoval, T, Baselga, J, Norton, L, Hudis, C. A., Dang, C. T.
Foilsithe in Breast Cancer Res Treat (2016)

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Tria...

le Freedman, Rachel A., Seisler, D. K., Foster, J. C., Sloan, J. A., Lafky, J. M., Kimmick, G. G., Hurria, A., Cohen, H. J., Winer, E. P., Hudis, C. A., Partridge, A. H., Carey, L. A., Jatoi, A., Klepin, H. D., Citron, M., Berry, D. A., Shulman, L. N., Buzdar, A. U., Suman, V. J., Muss, H. B.
Foilsithe in Breast Cancer Res Treat (2016)

Predicting response and survival in chemotherapy-treated triple-negative breast cancer

le Prat, A, Lluch, A, Albanell, J, Barry, W T, Fan, C, Chacón, J I, Parker, J S, Calvo, L, Plazaola, A, Arcusa, A, Seguí-Palmer, M A, Burgues, O, Ribelles, N, Rodriguez-Lescure, A, Guerrero, A, Ruiz-Borrego, M, Munarriz, B, López, J A, Adamo, B, Cheang, M C U, Li, Y, Hu, Z, Gulley, M L, Vidal, M J, Pitcher, B N, Liu, M C, Citron, M L, Ellis, M J, Mardis, E, Vickery, T, Hudis, C A, Winer, E P, Carey, L A, Caballero, R, Carrasco, E, Martín, M, Perou, C M, Alba, E
Foilsithe 2014